Refine
Has Fulltext
- yes (134)
Is part of the Bibliography
- yes (134)
Year of publication
Document Type
- Journal article (112)
- Doctoral Thesis (22)
Language
- English (134) (remove)
Keywords
- tissue engineering (11)
- Tissue Engineering (10)
- regenerative medicine (7)
- stem cells (6)
- in vitro (5)
- 3D tissue model (4)
- extracellular matrix (4)
- gene expression (4)
- inflammation (4)
- BMP-2 (3)
- Bordetella pertussis (3)
- bone regeneration (3)
- chondrocytes (3)
- collagens (3)
- decellularization (3)
- electrospinning (3)
- vascularization (3)
- 3D tumour model (2)
- B cells (2)
- BMP (2)
- Bone morphogenetic protein-2 (2)
- Cancer (2)
- Dünndarm (2)
- Hirschsprung disease (2)
- Implantat (2)
- In vitro (2)
- In-vitro-Kultur (2)
- Neisseria gonorrhoeae (2)
- Regenerative Medizin (2)
- SARS-CoV-2 (2)
- anthocyanins (2)
- bioengineering (2)
- biological models (2)
- bioreactor (2)
- blood-brain barrier (BBB) model (2)
- cartilage regeneration (2)
- co-culture (2)
- colorectal cancer (2)
- discriminant analysis (2)
- extracellular vesicles (2)
- growth factor beta (2)
- immunotherapy (2)
- impedance spectroscopy (2)
- infection (2)
- intestinal in vitro model (2)
- invasion (2)
- lung cancer (2)
- mesenchymal stem cells (2)
- migration (2)
- multiple myeloma (2)
- osteoarthritis (2)
- pancreas (2)
- permeability (2)
- phenotype (2)
- principal component analysis (2)
- raman spectroscopy (2)
- rat (2)
- reconstructed human epidermis (2)
- scaffolds (2)
- subcutaneous animal model (2)
- targeted therapy (2)
- therapy (2)
- 1st-line treatment (1)
- 3D (1)
- 3D Modell (1)
- 3D Tumormodell (1)
- 3D in vitro models (1)
- 3D lung tumor model (1)
- 3D lung tumor tissue models (1)
- 3D model (1)
- 3D models (1)
- 3D scaffolds (1)
- 3D tissue models (1)
- 5-Fluorouracil (1)
- ATMP (1)
- Adenylate cyclase toxin (1)
- Aggregatibacter actinomycetemcomitans (1)
- Alternative test methods (1)
- Alzheimer′s disease (1)
- Angiogenese (1)
- Apoptosis (1)
- Articular-Cartilage (1)
- Assay (1)
- Atemwege (1)
- Atemwegsschleimhaut (1)
- Automation (1)
- B cell receptors (1)
- BMP signaling (1)
- BMP-2 delivery (1)
- BRAF mutation (1)
- BRAF-mutant (1)
- BRAF-mutiert (1)
- Bakterielle Nanocellulose (1)
- Bauchspeicheldrüse (1)
- Beta-catenin (1)
- Bindegewebe (1)
- BioVaSc (1)
- Biocompatibility (1)
- Biodegradable polymer scaffolds (1)
- Biomechanical Properties (1)
- Biomedical engineering (1)
- Bioreactor (1)
- Blood-brain barrier (1)
- Blut-Hirn-Schranke (1)
- Bone morphogenetic protein 2 (1)
- Bone tissue engineering (1)
- Boolean signaling network (1)
- Brustkrebs (1)
- CAR T cell (1)
- CCR2 (1)
- CCR4 (1)
- CNS disease (1)
- CYP induction (1)
- CYP inhibition (1)
- CYR61 (1)
- Caco2 cells (1)
- Carcinoma cells (1)
- Cardiac ventricles (1)
- Cell replacement therapy (1)
- Chemicals (1)
- Collagen (1)
- Compressive Properties (1)
- Data acquisition (1)
- Dezellularisierung (1)
- Diabetes mellitus (1)
- Dickdarmtumor (1)
- Diffusion tensor imaging (1)
- Draize eye test (1)
- Drug testing (1)
- ECM coating (1)
- EMT (1)
- EVs (1)
- Eigenvectors (1)
- Electrochemical Impedance Spectroscopy (1)
- Electrode (1)
- Electrospinning (1)
- Elektrospinnen (1)
- Enteric nervous system (1)
- Enteric neuropathies (1)
- Episkin (1)
- Eriodictyon californicum (1)
- Extrazellulärmatrix (1)
- FGF signaling (1)
- FTIR spectroscopy (1)
- Fibroblasts (1)
- Fluorouracil (1)
- GDF-5 (1)
- GLP-1 (1)
- GLUTs (1)
- GMP (1)
- GUT (1)
- Gene regulation (1)
- Gewebemodelle (1)
- Glucose transport (1)
- Growth; BMP-2 (1)
- HSP90 inhibitor (1)
- HUVEC (1)
- Head and neck cancers (1)
- Heart (1)
- Hemofiltration (1)
- Hirschsprung disease liability (1)
- Human Knee (1)
- Human Medial Meniscus (1)
- Humanparasitologie (1)
- Hyaliner Knorpel (1)
- Hypertrophic pyloric-stenosis (1)
- IL-1ß (1)
- IL-6 (1)
- Immuntherapie (1)
- In vitro skin irritation testing (1)
- In-vitro (1)
- In-vivo (1)
- Induced pluripotent stem cells (1)
- Induzierte pluripotente Stammzelle (1)
- Infektionsstudien (1)
- Injuries (1)
- Intestinal pseudoobstruction (1)
- Intestinal stem cell (1)
- Invasion (1)
- Irritable bowel syndrome (1)
- KRAS biomarker signatures (1)
- KRAS mutation signature (1)
- Knochenimplantat (1)
- Knochenregeneration (1)
- Krebs <Medizin> (1)
- LCST (1)
- Lgr5 (1)
- Lungenkrebs (1)
- MSC (1)
- Magnetic resonance imaging (1)
- Mamma carcinoma (1)
- Mammakarzinom (1)
- Mandibular continuity defects (1)
- Marrow stromal cells (1)
- Matrix (1)
- Mechanical deformation (1)
- Mechanisms (1)
- Medicine (1)
- Medizinprodukt (1)
- Melanom (1)
- Mesenchymal transition (1)
- Microenvironment (1)
- Model (1)
- Models (1)
- Molekularbiologie (1)
- Monitoring (1)
- Multicenter randomized-trial (1)
- Multilayered skin tissue model (1)
- Myofibroblast differentiation (1)
- NK cells (1)
- NOTCH (1)
- NRAS mutation (1)
- Neisseria meningitidis (1)
- Neural crest cells (1)
- Nitric-oxide (1)
- OECD guideline (1)
- OLFM4 (1)
- Onchocerca volvulus (1)
- Onchozerkose (1)
- Open source reconstructed epidermis (1)
- Oral squamous cell carcinoma (1)
- Osteoarthritis (1)
- Oxide synthase gene (1)
- Pancreatic islet (1)
- Pankreas (1)
- Parasitology (1)
- Perfusion Bioreactor (1)
- Primär-basierte immortalisierte Zelllinie (1)
- Proliferation (1)
- Protein chemistry (1)
- R57A (1)
- RHE (1)
- Rat mynteric plexus (1)
- Receptor (1)
- Repair (1)
- SGLTs (1)
- Salmonella (1)
- Salmonella Typhimurium (1)
- Scaffold bone implant (1)
- Sglt1 (1)
- Sinus floor augmentation (1)
- Skin Tissue Engineering (1)
- Slow-transit constipation (1)
- Smooth-muscle-cells (1)
- Squamous-cell carcinoma (1)
- Stammzelle (1)
- Stem cells (1)
- Stem-cell biotechnology (1)
- Streptococcus oralis (1)
- Stroma (1)
- Swine (1)
- TEER (1)
- TGF-beta (1)
- TGFβ/BMP signaling (1)
- TNBC (1)
- Targeted therapies (1)
- Term follow-up (1)
- Test system (1)
- Therapeutisches System (1)
- Therapie (1)
- Therapiesimulation (1)
- Tissue (1)
- Tractography (1)
- Triple co-culture (1)
- Tumor models (1)
- Tumorigenicity (1)
- Tumormikroumgebung (1)
- Validation (1)
- Vascularized (1)
- Vaskularisation (1)
- Vaskularisierung (1)
- Vivo (1)
- Wirkstofftestung (1)
- Zelldifferenzierung (1)
- acetylsalicylic acid (1)
- acid dissociation (1)
- adenocarcinoma of the lung (1)
- adenylate cyclase toxin (1)
- adhesion (1)
- adults (1)
- aging (1)
- air-liquid interface (1)
- airway epithelia (1)
- albumins (1)
- algorithm (1)
- alternative to animal testing (1)
- alternatives (1)
- anaesthetics (1)
- anatomy (1)
- animal model (1)
- antagonist (1)
- antennas (1)
- anthocyanin (1)
- antibiotics (1)
- antioxidative (1)
- antitumor peptide (1)
- antiviral activity (1)
- apoptosis (1)
- artificial membrane-permeability (1)
- aspirin (1)
- astaxanthin (1)
- asthmatic bronchial epithelium (1)
- astrocytes (1)
- autologous (1)
- autologous chondrocyte implantation (1)
- automation (1)
- automation & robotics (1)
- bacteria (1)
- bacterial cellulose dressing (1)
- bacterial migration (1)
- bacterial nanocellulose (1)
- bacterial virulence (1)
- barrier models (1)
- benzalkonium chloride (1)
- beta cell (1)
- beta-aminopropionitrile (1)
- beta-cyclodextrin (1)
- betaglycan (1)
- bilberry (1)
- biocompatibility (1)
- biocompatible materials (1)
- bioconjugation (1)
- biofilm (1)
- bioinformatics (1)
- biological barriers (1)
- biological scaffold (1)
- biological scaffolds (1)
- biology (1)
- biomaterial tests (1)
- biomedical engineering (1)
- biomedical materials (1)
- biomimetic 3D tissue model (1)
- bioreactor culture (1)
- biotechnology (1)
- black currant (1)
- blood (1)
- blood glucose regulation (1)
- blood pressure (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- blood‐brain barrier (BBB) (1)
- bone (1)
- bone critical size defect (1)
- bone marrow (1)
- bone morphogenetic protein (1)
- bone morphogenetic protein 2 (BMP2) (1)
- bone morphogenetic protein 9 (BMP9) (1)
- bone morphogenetic proteins (1)
- bone tissue engineering (1)
- boolean in silico models (1)
- brachtydacyly type A2 (1)
- brain endothelial cells (1)
- brain–liver chip (1)
- breast cancer cells (1)
- burn wound (1)
- calcium fluoride nanoparticles (1)
- cancer dissemination (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- carbon fiber (1)
- cardiac device therapy (1)
- cardiac patch (1)
- cardiac tissue (1)
- cardiovascular (1)
- cardiovascular MR methods (1)
- cartilage (1)
- cartilage defectex vivo model (1)
- cartilage repair (1)
- cartilage test system (1)
- cell binding (1)
- cell culture (1)
- cell cultures (1)
- cell cycle and cell division (1)
- cell differentiation (1)
- cell engineering (1)
- cell membrane model (1)
- cell metabolism (1)
- cell migration (1)
- cell proliferation (1)
- cellular biology (1)
- cellular microenvironment (1)
- cellular signalling networks (1)
- central nervous system (1)
- ceramide (1)
- chemokine receptor (1)
- chemoresistance (1)
- chiral resolution (1)
- chondrogenesis (1)
- chondrogenic differentiation (1)
- chondrogenic hypertrophy (1)
- ciliary neurotrophic factor (1)
- ciliostasis (1)
- circular dichroism (1)
- clinical applications (1)
- collagen sponge (1)
- collagen type I hydrogel (1)
- colon (1)
- colony-stimulating factor (1)
- combination of physical vapor deposition and electrochemical etching (1)
- combinatorial drug predictions (1)
- complexation (1)
- computer modelling (1)
- confocal Raman imaging (1)
- core depression (1)
- coreceptor (1)
- corneal endothelium (1)
- corneal epithelium (1)
- corneal equivalent (1)
- corneal storage (1)
- covalent coupling (1)
- critical size defect (1)
- cross-talk (1)
- cryostructured scaffolds (1)
- crystal structure (1)
- crystal-structure (1)
- culture techniques (1)
- cultured (1)
- cyclic adenosine monophosphate (1)
- cycloaddition (1)
- cyclodextrin (1)
- cytokine (1)
- cytokines (1)
- cytotoxicity (1)
- defects (1)
- defined humanized test system (1)
- dendritic cell (1)
- dental implants (1)
- diabetes (1)
- differentiation (1)
- diffusion tensor imaging (1)
- dominant-negative mutatio (1)
- drug (1)
- drug delivery (1)
- drug metabolism (1)
- drug permeability screening (1)
- drug resistance (1)
- dry spinning (1)
- dynamic culture (1)
- dynamic culture conditions (1)
- dystrophic RCS rats (1)
- early diagnosis (1)
- ectopic bone formation (1)
- elastic fibers (1)
- elastin (1)
- electrical and electronic engineering (1)
- embryonic stem cell (1)
- embryonic stem cells (1)
- endothelial cells (1)
- endothelial growth factor (1)
- enteric nervous system (1)
- enzyme metabolism (1)
- epidermis (1)
- epithelial cell culture (1)
- epithelial cells (1)
- equipment and supplies (1)
- establishment (1)
- ex vivo model (1)
- experimental models of disease (1)
- expression (1)
- eye irritation testing (1)
- factor binding profiles (1)
- factor-VIII (1)
- fibroblast chemotaxis (1)
- fibroblast growth factor (1)
- fibrosis (1)
- filamentous Salmonella Typhimurium (1)
- fixation (1)
- flavonoids (1)
- follistatin 288 (FST288) (1)
- follistatin 315 (FST315) (1)
- foreign body reaction (1)
- formalin (1)
- full thickness skin (1)
- functional initiators (1)
- gamma-cyclodextrin (1)
- gastrointestinal tract (1)
- gels (1)
- gene encoding noggin (1)
- gene therapy (1)
- genetic engineering (1)
- glucose (1)
- glucose transporter SGLT1 (1)
- glycoprotein (1)
- growth and differentiation factor 5 (1)
- hBMSC (1)
- head and neck squamous cell carcinoma (1)
- heart structure (1)
- heart valve (1)
- heparin binding sites (1)
- heptaocytes (1)
- herpesvirus (1)
- highly porous materials (1)
- host (1)
- host modulation (1)
- human (1)
- human airway mucosa tissue models (1)
- human bruchs membrane (1)
- human exposure (1)
- human heptocytes (1)
- human induced pluripotent stem cells (hiPSCs) (1)
- human induced pluripotent stem cells (hiPSCs)human induced pluripotent stem cells (hiPSCs) (1)
- human liver cells (1)
- human nasal epithelial cells (1)
- human osteosarcoma xenografts (1)
- human respiratory epithelial cells (1)
- human tracheo-bronchial epithelial cells (1)
- human‐induced pluripotent stem cells (hiPSC) (1)
- hyaline cartilage (1)
- hybrid pacemaker (1)
- hyperlipidemia (1)
- hypoxia inducible factor 1 (1)
- immune cell infiltration (1)
- immunotherapeutics (1)
- immunotherapies (1)
- implant (1)
- in silico simulation (1)
- in situ guided tissue regeneration (1)
- in vitro Modelle (1)
- in vitro models (1)
- in vitro-Testsystem (1)
- in vivo (1)
- in vivo experiments (1)
- in vivo study (1)
- in-vitro (1)
- in-vitro models (1)
- induced pluripotent stem cells (1)
- induction (1)
- infectious disease (1)
- inflammation-induced tissue demage (1)
- inflammatory bowel disease (1)
- inflammatory response (1)
- injectable in situ gelling slow release system (1)
- insilico drug screening too (1)
- insulin (1)
- interface (1)
- intestinal enteroids (1)
- intestine (1)
- invasiveness (1)
- inflammatory response (1)
- iron metabolism (1)
- irradiation (1)
- islets of Langerhans (1)
- kinetics (1)
- kolorektales Karzinom (1)
- label-free analysis (1)
- laser microdissection (1)
- ligand binding (1)
- ligand-receptor complex (1)
- ligand-receptor promiscuity (1)
- lipids (1)
- liposome (1)
- living cells (1)
- lncRNAs (1)
- long-term (1)
- lower critical solution temperature (1)
- lung and intrathoracic tumors (1)
- magnetic resonance imaging (MRI) (1)
- malignant tumors (1)
- manufacturing (1)
- measels virus (1)
- measles virus (1)
- mechanisms of disease (1)
- medicine (1)
- melanoma metastases (1)
- membrane receptor signaling (1)
- memory (1)
- meningococcus (1)
- mesenchymal cells (1)
- mesenchymal stromal cell (1)
- mesenchymal tissues (1)
- mesothelium (1)
- metabolic flux analysis (1)
- metallo-supramolecular polymer (1)
- miRNAs (1)
- microbe carrier (1)
- microenvironment (1)
- microparticles (1)
- microphysiologic 3D tumour model (1)
- microphysiological systems (MPS) (1)
- microplastics (1)
- microvascular endothelial cells (1)
- microwave radiation (1)
- midazolam (1)
- modular tumor tissue models (1)
- moisture balance (1)
- molecular biology (1)
- molecular diagnostics (1)
- molecular mechanism (1)
- morphogenetic protein receptors (1)
- motility disorders (1)
- multi-organ chip (1)
- multicellular tumor spheroids (1)
- multifunctional nanoparticles (1)
- multilayered skin (1)
- multimodal imaging (1)
- multipotent fetal neural stem cells (fNSCs) (1)
- multivariate data analysis (1)
- murine (1)
- mutagenesis (1)
- myenteric plexus (1)
- nanoparticles (1)
- nanoplastics (1)
- nanotopographical surfaces (1)
- necrosis-factor-alpha (1)
- necrotic cell death (1)
- neural stem-cell (1)
- neurology (1)
- neuronal electrodes (1)
- neurotoxicity (1)
- neurovascular unit in vitro (1)
- neutrophil transmigration (1)
- non-invasive biomarkers (1)
- occupancy (1)
- olfactomedin 4 (1)
- on-a-chip (1)
- open-access database (1)
- open-source epidermis (1)
- oragnoids (1)
- organ-on-a-chip (1)
- organotypic (1)
- organotypic oral mucosa (1)
- osteoblasts (1)
- osteochondral allografts (1)
- osteochondral biopsy (1)
- osteochondral lesion (1)
- osteogenesis (1)
- osteogenesis imperfecta (1)
- osteogenic differentiation (1)
- osteoporosis (1)
- outgrowth endothelial cells (1)
- ovarian cancer (1)
- oxidative DNA damage (1)
- pancreatic cancer (1)
- pancreatic differentiation (1)
- pancreatic islet cytomorphology (1)
- pancreatic islet function (1)
- parasitology (1)
- perfused hydrogel (1)
- perfusion-based bioreactor system (1)
- peritoneal metastasis (1)
- pharmaceutical applications (1)
- phosphatidylserine (1)
- photoluminescence (1)
- physiology (1)
- platelet-derived growth factor (1)
- pluripotent stem cells (1)
- polymer (1)
- polymerization (1)
- polymers (1)
- polypeptoids (1)
- postpolymerization modification (1)
- precision-cut lung slices (1)
- preclinical drug discovery (1)
- primary cell isolation (1)
- primary cells (1)
- primary human hepatocytes (1)
- primary-cell-derived immortalized cell line (1)
- progenitor cells (1)
- progenitors (1)
- protein immobilization (1)
- proteins (1)
- pulmonary drug-delivery (1)
- pulmonary imaging (1)
- pulses (1)
- quanititative characterization (1)
- quantification (1)
- randomized clinical trial (1)
- reactive oxygen species (1)
- real time PCR (1)
- receptor type III (1)
- reflection (1)
- relaxometry (1)
- repair (1)
- replacement (1)
- respiratory syncytial virus (1)
- responses (1)
- retinal pigment epithelium (1)
- rhBMP–2 (1)
- ring-opening polymerization (1)
- salicylic acid (1)
- salivary gland neoplasia (1)
- salivary gland tumor (1)
- salivary gland tumors (1)
- salivary glands (1)
- scaffold (1)
- scanning electron microscopy (1)
- secondary lung tumors (1)
- secondary wound dressing (1)
- segmental collapse (1)
- sevoflurane (1)
- sheep model (1)
- signal integration (1)
- signal specification (1)
- signal tranduction (1)
- signal transduction (1)
- signaling (1)
- signaling pathways (1)
- site directed immobilization (1)
- site-specific immobilization (1)
- skin anatomy (1)
- skin equivalents (1)
- skin model (1)
- skin models (1)
- skin physiology (1)
- small intestinal submucosa scaffold (1)
- sodium channels (1)
- sol-gel chemistry (1)
- solid tumors (1)
- solid tumour (1)
- solubility (1)
- sphingosine-1-phosphate (1)
- starch (1)
- stemness (1)
- sterubin (1)
- stimulation (1)
- stratification (1)
- stromal cells (1)
- stromal tissues (1)
- subfoveal choroidal neovascularization (1)
- subretinal space (1)
- superfamily (1)
- supermolecular carrier systems (1)
- surgical oncology (1)
- systemic inflammatory response syndrome (1)
- targeted combination therapy (1)
- technology (1)
- therapy simulation (1)
- tight junction (1)
- tissue culture (1)
- tissue model (1)
- tissue preparation (1)
- tissue remodeling (1)
- toxicity (1)
- toxicology (1)
- trachea (1)
- tracheal cytotoxin (1)
- trafficking (1)
- transcapillary pressure gradient (1)
- transcriptomics (1)
- transforming growth factor-beta 1 (1)
- translational research (1)
- translocation (1)
- transplantation (1)
- transport studies (1)
- tumor cells (1)
- tumor model systems (1)
- tumor test system (1)
- tumour (1)
- tumour microenvironment (1)
- tumour stroma (1)
- upcyte hepatocytes (1)
- vascular normalization (1)
- vascular progenitor (1)
- vascular surgery (1)
- vascularized scaffold (1)
- vesicle-based barrier (1)
- viral epidemiology (1)
- viral infection (1)
- virulence (1)
- weight-bearing (1)
- wound healing (1)
- wound model (1)
- wound physiology (1)
- xenotransplantation (1)
- zielgerichtete Behandlung (1)
- zinc oxide nanoparticles (1)
- α-Cell (1)
- α-cell (1)
- β-Cell (1)
- β-cell (1)
Institute
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (134) (remove)
Sonstige beteiligte Institutionen
Purpose:
The biologic relevance of human connective tissue growth factor (hCTGF) for primary human tenon fibroblasts (HTFs) was investigated by RNA expression profiling using affymetrix (TM) oligonucleotide array technology to identify genes that are regulated by hCTGF.
Methods:
Recombinant hCTGF was expressed in HEK293T cells and purified by affinity and gel chromatography. Specificity and biologic activity of hCTGF was confirmed by biosensor interaction analysis and proliferation assays. For RNA expression profiling HTFs were stimulated with hCTGF for 48h and analyzed using affymetrix (TM) oligonucleotide array technology. Results were validated by real time RT-PCR.
Results:
hCTGF induces various groups of genes responsible for a wound healing and inflammatory response in HTFs. A new subset of CTGF inducible inflammatory genes was discovered (e.g., chemokine [C-X-C motif] ligand 1 [CXCL1], chemokine [C-X-C motif] ligand 6 [CXCL6], interleukin 6 [IL6], and interleukin 8 [IL8]). We also identified genes that can transmit the known biologic functions initiated by CTGF such as proliferation and extracellular matrix remodelling. Of special interest is a group of genes, e.g., osteoglycin (OGN) and osteomodulin (OMD), which are known to play a key role in osteoblast biology.
Conclusions:
This study specifies the important role of hCTGF for primary tenon fibroblast function. The RNA expression profile yields new insights into the relevance of hCTGF in influencing biologic processes like wound healing, inflammation, proliferation, and extracellular matrix remodelling in vitro via transcriptional regulation of specific genes. The results suggest that CTGF potentially acts as a modulating factor in inflammatory and wound healing response in fibroblasts of the human eye.
Non-contact, Label-free Monitoring of Cells and Extracellular Matrix using Raman Spectroscopy
(2012)
Non-destructive, non-contact and label-free technologies to monitor cell and tissue cultures are needed in the field of biomedical research.1-5 However, currently available routine methods require processing steps and alter sample integrity. Raman spectroscopy is a fast method that enables the measurement of biological samples without the need for further processing steps. This laser-based technology detects the inelastic scattering of monochromatic light.6 As every chemical vibration is assigned to a specific Raman band (wavenumber in cm-1), each biological sample features a typical spectral pattern due to their inherent biochemical composition.7-9 Within Raman spectra, the peak intensities correlate with the amount of the present molecular bonds.1 Similarities and differences of the spectral data sets can be detected by employing a multivariate analysis (e.g. principal component analysis (PCA)).10
Here, we perform Raman spectroscopy of living cells and native tissues. Cells are either seeded on glass bottom dishes or kept in suspension under normal cell culture conditions (37 °C, 5% CO2) before measurement. Native tissues are dissected and stored in phosphate buffered saline (PBS) at 4 °C prior measurements. Depending on our experimental set up, we then either focused on the cell nucleus or extracellular matrix (ECM) proteins such as elastin and collagen. For all studies, a minimum of 30 cells or 30 random points of interest within the ECM are measured. Data processing steps included background subtraction and normalization.
In situ guided tissue regeneration, also addressed as in situ tissue engineering or endogenous regeneration, has a great potential for population-wide “minimal invasive” applications. During the last two decades, tissue engineering has been developed with remarkable in vitro and preclinical success but still the number of applications in clinical routine is extremely small. Moreover, the vision of population-wide applications of ex vivo tissue engineered constructs based on cells, growth and differentiation factors and scaffolds, must probably be deemed unrealistic for economic and regulation-related issues. Hence, the progress made in this respect will be mostly applicable to a fraction of post-traumatic or post-surgery situations such as big tissue defects due to tumor manifestation. Minimally invasive procedures would probably qualify for a broader application and ideally would only require off the shelf standardized products without cells. Such products should mimic the microenvironment of regenerating tissues and make use of the endogenous tissue regeneration capacities. Functionally, the chemotaxis of regenerative cells, their amplification as a transient amplifying pool and their concerted differentiation and remodeling should be addressed. This is especially important because the main target populations for such applications are the elderly and diseased. The quality of regenerative cells is impaired in such organisms and high levels of inhibitors also interfere with regeneration and healing. In metabolic bone diseases like osteoporosis, it is already known that antagonists for inhibitors such as activin and sclerostin enhance bone formation. Implementing such strategies into applications for in situ guided tissue regeneration should greatly enhance the efficacy of tailored procedures in the future.
Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head
(2012)
Avascular necrosis (AVN) of the femoral head is a debilitating disease of multifactorial genesis, predominately affects young patients, and often leads to the development of secondary osteoarthritis. The evolving field of regenerative medicine offers promising treatment strategies using cells, biomaterial scaffolds, and bioactive factors, which might improve clinical outcome. Early stages of AVN with preserved structural integrity of the subchondral plate are accessible to retrograde surgical procedures, such as core decompression to reduce the intraosseous pressure and to induce bone remodeling. The additive application of concentrated bone marrow aspirates, ex vivo expanded mesenchymal stem cells, and osteogenic or angiogenic growth factors (or both) holds great potential to improve bone regeneration. In contrast, advanced stages of AVN with collapsed subchondral bone require an osteochondral reconstruction to preserve the physiological joint function. Analogously to strategies for osteochondral reconstruction in the knee, anterograde surgical techniques, such as osteochondral transplantation (mosaicplasty), matrix-based autologous chondrocyte implantation, or the use of acellular scaffolds alone, might preserve joint function and reduce the need for hip replacement. This review summarizes recent experimental accomplishments and initial clinical findings in the field of regenerative medicine which apply cells, growth factors, and matrices to address the clinical problem of AVN.
Growth and Differentiation Factor 5 (GDF5) is a secreted growth factor that belongs to the Bone Morphogenetic Protein (BMP) family and plays a pivotal role during limb development. GDF5 is a susceptibility gene for osteoarthritis (OA) and mutations in GDF5 are associated with a wide variety of skeletal malformations ranging from complex syndromes such as acromesomelic chondrodysplasias to isolated forms of brachydactylies or multiple synostoses syndrome 2 (SYNS2). Here, we report on a family with an autosomal dominant inherited combination of SYNS2 and additional brachydactyly type A1 (BDA1) caused by a single point mutation in GDF5 (p.W414R). Functional studies, including chondrogenesis assays with primary mesenchymal cells, luciferase reporter gene assays and Surface Plasmon Resonance analysis, of the GDF5 W-414R variant in comparison to other GDF5 mutations associated with isolated BDA1 (p.R399C) or SYNS2 (p.E491K) revealed a dual pathomechanism characterized by a gain-and loss-of-function at the same time. On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype. Whereas on the other hand, a reduced signaling activity, specifically via the BMP receptor type IA (BMPR1A), is likely responsible for the BDA1 phenotype. These results demonstrate that one mutation in the overlapping interface of antagonist and receptor binding site in GDF5 can lead to a GDF5 variant with pathophysiological relevance for both, BDA1 and SYNS2 development. Consequently, our study assembles another part of the molecular puzzle of how loss and gain of function mutations in GDF5 affect bone development in hands and feet resulting in specific types of brachydactyly and SYNS2. These novel insights into the biology of GDF5 might also provide further clues on the pathophysiology of OA.
Cancer is one of the leading causes of death worldwide. Current therapeutic strategies are predominantly developed in 2D culture systems, which inadequately reflect physiological conditions in vivo. Biological 3D matrices provide cells an environment in which cells can self-organize, allowing the study of tissue organization and cell differentiation. Such scaffolds can be seeded with a mixture of different cell types to study direct 3D cell-cell-interactions. To mimic the 3D complexity of cancer tumors, our group has developed a 3D in vitro tumor test system.
Our 3D tissue test system models the in vivo situation of malignant peripheral nerve sheath tumors (MPNSTs), which we established with our decellularized porcine jejunal segment derived biological vascularized scaffold (BioVaSc). In our model, we reseeded a modified BioVaSc matrix with primary fibroblasts, microvascular endothelial cells (mvECs) and the S462 tumor cell line For static culture, the vascular structure of the BioVaSc is removed and the remaining scaffold is cut open on one side (Small Intestinal Submucosa SIS-Muc). The resulting matrix is then fixed between two metal rings (cell crowns).
Another option is to culture the cell-seeded SIS-Muc in a flow bioreactor system that exposes the cells to shear stress. Here, the bioreactor is connected to a peristaltic pump in a self-constructed incubator. A computer regulates the arterial oxygen and nutrient supply via parameters such as blood pressure, temperature, and flow rate. This setup allows for a dynamic culture with either pressure-regulated pulsatile or constant flow.
In this study, we could successfully establish both a static and dynamic 3D culture system for MPNSTs. The ability to model cancer tumors in a more natural 3D environment will enable the discovery, testing, and validation of future pharmaceuticals in a human-like model.
Background
Fibrosis poses a substantial setback in regenerative medicine. Histopathologically, fibrosis is an excessive accumulation of collagen affected by myofibroblasts and this can occur in any tissue that is exposed to chronic injury or insult. Transforming growth factor (TGF)-β1, a crucial mediator of fibrosis, drives differentiation of fibroblasts into myofibroblasts. These cells exhibit α-smooth muscle actin (α-SMA) and synthesize high amounts of collagen I, the major extracellular matrix (ECM) component of fibrosis. While hormones stimulate cells in a pulsatile manner, little is known about cellular response kinetics upon growth factor impact. We therefore studied the effects of short TGF-β1 pulses in terms of the induction and maintenance of the myofibroblast phenotype.
Results
Twenty-four hours after a single 30 min TGF-β1 pulse, transcription of fibrogenic genes was upregulated, but subsided 7 days later. In parallel, collagen I secretion rate and α-SMA presence were elevated for 7 days. A second pulse 24 h later extended the duration of effects to 14 days. We could not establish epigenetic changes on fibrogenic target genes to explain the long-lasting effects. However, ECM deposited under singly pulsed TGF-β1 was able to induce myofibroblast features in previously untreated fibroblasts. Dependent on the age of the ECM (1 day versus 7 days’ formation time), this property was diminished. Vice versa, myofibroblasts were cultured on fibroblast ECM and cells observed to express reduced (in comparison with myofibroblasts) levels of collagen I.
Conclusions
We demonstrated that short TGF-β1 pulses can exert long-lasting effects on fibroblasts by changing their microenvironment, thus leaving an imprint and creating a reciprocal feed-back loop. Therefore, the ECM might act as mid-term memory for pathobiochemical events. We would expect this microenvironmental memory to be dependent on matrix turnover and, as such, to be erasable. Our findings contribute to the current understanding of fibroblast induction and maintenance, and have bearing on the development of antifibrotic drugs.
The zona pellucida (ZP) domain is present in extracellular proteins such as the zona pellucida proteins and tectorins and participates in the formation of polymeric protein networks. However, the ZP domain also occurs in the cytokine signaling co-receptor transforming growth factor beta (TGF-\(\beta\)) receptor type 3 (TGFR-3, also known as betaglycan) where it contributes to cytokine ligand recognition. Currently it is unclear how the ZP domain architecture enables this dual functionality. Here, we identify a novel major TGF-beta-binding site in the FG loop of the C-terminal subdomain of the murine TGFR-3 ZP domain (ZP-C) using protein crystallography, limited proteolysis experiments, surface plasmon resonance measurements and synthetic peptides. In the murine 2.7 angstrom crystal structure that we are presenting here, the FG-loop is disordered, however, well-ordered in a recently reported homologous rat ZP-C structure. Surprisingly, the adjacent external hydrophobic patch (EHP) segment is registered differently in the rat and murine structures suggesting that this segment only loosely associates with the remaining ZP-C fold. Such a flexible and temporarily-modulated association of the EHP segment with the ZP domain has been proposed to control the polymerization of ZP domain-containing proteins. Our findings suggest that this flexibility also extends to the ZP domain of TGFR-3 and might facilitate co-receptor ligand interaction and presentation via the adjacent FG-loop. This hints that a similar C-terminal region of the ZP domain architecture possibly regulates both the polymerization of extracellular matrix proteins and cytokine ligand recognition of TGFR-3.
Age-related gene expression analysis in enteric ganglia of human colon after laser microdissection
(2014)
The enteric nervous system (ENS) poses the intrinsic innervation of the gastrointestinal tract and plays a critical role for all stages of postnatal life. There is increasing scientific and clinical interest in acquired or age-related gastrointestinal dysfunctions that can be manifested in diseases such as gut constipation or fecal incontinence. In this study, we sought to analyze age-dependent changes in the gene expression profile of the human ENS, particularly in the myenteric plexus. Therefore, we used the laser microdissection technique which has been proven as a feasible tool to analyze distinct cell populations within heterogeneously composed tissues. Full biopsy gut samples were prepared from children (4–12 months), middle aged (48–58 years) and aged donors (70–95 years). Cryosections were histologically stained with H&E, the ganglia of the myenteric plexus identified and RNA isolated using laser microdissection technique. Quantitative PCR was performed for selected neural genes, neurotransmitters and receptors. Data were confirmed on protein level using NADPH-diaphorase staining and immunohistochemistry. As result, we demonstrate age-associated alterations in site-specific gene expression pattern of the ENS. Thus, in the adult and aged distal parts of the colon a marked decrease in relative gene expression of neural key genes like NGFR, RET, NOS1 and a concurrent increase of CHAT were observed. Further, we detected notable regional differences of RET, CHAT, TH, and S100B comparing gene expression in aged proximal and distal colon. Interestingly, markers indicating cellular senescence or oxidative stress (SNCA, CASP3, CAT, SOD2, and TERT) were largely unchanged within the ENS. For the first time, our study also describes the age-dependent expression pattern of all major sodium channels within the ENS. Our results are in line with previous studies showing spatio-temporal differences within the mammalian ENS.
Recent advances in the in vitro characterization of human adult enteric neural progenitor cells have opened new possibilities for cell-based therapies in gastrointestinal motility disorders. However, whether these cells are able to integrate within an in vivo gut environment is still unclear. In this study, we transplanted neural progenitor-containing neurosphere-like bodies (NLBs) in a mouse model of hypoganglionosis and analyzed cellular integration of NLB-derived cell types and functional improvement. NLBs were propagated from postnatal and adult human gut tissues. Cells were characterized by immunohistochemistry, quantitative PCR and subtelomere fluorescence in situ hybridization (FISH). For in vivo evaluation, the plexus of murine colon was damaged by the application of cationic surfactant benzalkonium chloride which was followed by the transplantation of NLBs in a fibrin matrix. After 4 weeks, grafted human cells were visualized by combined in situ hybridization (Alu) and immunohistochemistry (PGP9.5, GFAP, SMA). In addition, we determined nitric oxide synthase (NOS)-positive neurons and measured hypertrophic effects in the ENS and musculature. Contractility of treated guts was assessed in organ bath after electrical field stimulation. NLBs could be reproducibly generated without any signs of chromosomal alterations using subtelomere FISH. NLB-derived cells integrated within the host tissue and showed expected differentiated phenotypes i.e. enteric neurons, glia and smooth muscle-like cells following in vivo transplantation. Our data suggest biological effects of the transplanted NLB cells on tissue contractility, although robust statistical results could not be obtained due to the small sample size. Further, it is unclear, which of the NLB cell types including neural progenitors have direct restoring effects or, alternatively may act via 'bystander' mechanisms in vivo. Our findings provide further evidence that NLB transplantation can be considered as feasible tool to improve ENS function in a variety of gastrointestinal disorders.